Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

A Brunner

Physician Assistant Stockbridge, GA Physician Assistant

NPI 1811993223 CMS profile 11067817

210 Village Center Pkwy Ste B, Na, Stockbridge, GA 30281

Open in the dashboard

General payments

$1,033,101

1,264 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, A Brunner of Stockbridge, GA is reported in the CMS Open Payments database as having received $1,033,101 across 1,264 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $352,856 326
2024 General $257,546 179
2023 General $142,351 316
2022 General $160,693 268
2021 General $119,654 175

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • A Brunner
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to A Brunner were reported at $352,856. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year A Brunner Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $119,654 $132 $37–$438 $132
2022 $160,693 $155 $48–$522 $149
2023 $142,351 $167 $52–$557 $160
2024 $257,546 $178 $55–$600 $164
2025 $352,856 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. AbbVie, Inc. $506,699 114 payments
  2. Sun Pharmaceutical Industries Inc. $210,435 343 payments
  3. Janssen Biotech, Inc. $72,813 151 payments
  4. Ortho Dermatologics, a division of Bausch Health US, LLC $61,200 37 payments
  5. LEO Pharma Inc. $48,362 141 payments
  6. E.R. Squibb & Sons, L.L.C. $21,212 65 payments
  7. Janssen Scientific Affairs, LLC $19,088 29 payments
  8. Novartis Pharmaceuticals Corporation $16,346 38 payments
  9. Boehringer Ingelheim Pharmaceuticals, Inc. $15,017 25 payments
  10. Dermavant Sciences, Inc. $12,970 31 payments
  11. Other $48,959 290 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Grant $484,900 7 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $199,238 81 payments
  3. Consulting Fee $139,884 124 payments
  4. Travel and Lodging $71,180 302 payments
  5. Honoraria $53,224 20 payments
  6. Compensation for serving as faculty or as a speaker for a medical education program $41,700 16 payments
  7. Food and Beverage $31,260 703 payments
  8. Education $11,714 11 payments
Products named General payments · program years 2021–2025
  1. RINVOQ $259,848 48 payments
  2. SKYRIZI Immunology $193,136 10 payments
  3. Winlevi $124,953 223 payments
  4. TREMFYA $91,872 178 payments
  5. SKYRIZI Immunology $53,633 46 payments
  6. ADBRY $38,521 109 payments
  7. Absorica LD $37,430 46 payments
  8. ILUMYA $34,694 55 payments
  9. ARAZLO $28,101 11 payments
  10. Leqselvi $27,183 43 payments
  11. Other $130,614 530 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 7 drugs

Part D claims

146

Median for Physician Assistant: 241

Drug cost

$50,227

Median for Physician Assistant: $4,110

Branded share of claims

17.1%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Adbry Tralokinumab-Ldrm Brand 11 $47,870
Doxycycline Hyclate Generic 31 $703
Betamethasone Diprop Augmented Betamethasone/Propylene Glyc Brand 14 $414
Triamcinolone Acetonide Generic 36 $396
Clobetasol Propionate Generic 14 $364
Ketoconazole Generic 19 $324
Hydrocortisone Generic 21 $155

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Payments and prescribing

First 5 of 26 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
RINVOQ
$163,519 — —
Winlevi
$23,126 — —
TREMFYA
$14,615 — —
JUBLIA
$7,500 — —
ARAZLO
$7,500 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See more in the dashboard: 25 with a free account, all 26 with Patron

Records

1,264 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in Georgia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record